Dysplastic nevus (atypical nevus);Nevo displásico (nevo atípico)

Anais Brasileiros de Dermatologia

Volumn 85, Issue 6, 2010, Pages 863-871

  Rezze, Gisele Gargantini ^a   Leon, Alexandre ^a,b   Duprat, João ^a,c  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b Fundação Antonio Prudente   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dermoscopy; Histology; Nevi and melanomas

Indexed keywords

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DYSPLASTIC NEVUS; EPILUMINESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; MELANOMA; MOLECULAR BIOLOGY; REVIEW; SUN EXPOSURE;

DERMOSCOPY; DIAGNOSIS, DIFFERENTIAL; DYSPLASTIC NEVUS SYNDROME; HUMANS; MELANOMA; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 79951669258     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962010000600013     Document Type: Review

References (39)

1. Clark Jr WH, Elder DE, Guerry Dt, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of the superficila spreading and nodular melanoma. Hum Pathol. 1984;15:1147-65. (Pubitemid 15128121)
2. Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Fraser MC, et al. Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet. 1980;2:1024. (Pubitemid 10025088)
3. Elder DE, Goldman LI, Goldman SC, Greene MH, Clark WH Jr. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980;46:1787-94. (Pubitemid 10011134)
4. Ackerman AB, Magana-Garcia M. Naming acquired melanocytic nevi. Unna's, Miescher's, Spitz's Clark's. AmJ Dermatopathol. 1990;12:193-209.
5. Fung MA. Terminology and management of dysplasticnevi: responses from 145 dermatologists. Arch Dermatol. 2003;139:1374-5. (Pubitemid 37248296)
6. Naeyaert JM, Brochez L. Clinical practice. Dysplastic nevi. N Engl J Med. 2003;349:2233-40.
7. NHI consensus Conference: diagnosis and treatment of early melanoma. JAMA. 1992;251:1314-09.
8. Hussein MR. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues. J Clin Pathol. 2005;58:453-6. (Pubitemid 40646863)
9. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol. 1995;33:1000-7.
10. Li G, Herlyn M. Dynamics of intercellular communication during melanoma development. Mol Med Today. 2000;6:163-9. (Pubitemid 30171367)
11. Chammas R, Duarte APM, Otake AH, Costa M. Genética e biologia molecular do melanoma e de sua progressão. In: Oliveira Filho RS, editor. Melanoma cutâneo localizado e linfonodo sentinela. São Paulo: Lemar; 2003. p.1-19.
12. Roesch A, Burgdorf W, Stolz W, Landthaler M, Vogt T. Dermatoscopy of "dysplastic nevi": a beacon in d iagnostic darkness. Eur J Dermatol. 2006;16:479-93.
13. Hofmann-Wellenhof R, Blum A, Wolf IH, Piccolo D, Kerl H, Garbe C, Soyer HP. Dermoscopic classification of atypical melanocytic nevi (Clark nevi). Arch Dermatol. 2001;137:1575-80. (Pubitemid 34000905)
14. Arumi-Uria M. Dysplastic nevus: the eye of the hurricane. J Cutan Pathol. 2008;35 Suppl 2:16-9.
15. Platz A, Ringborg U, Hansson J. Hereditary cutaneous melanoma. Semin Cancer Biol. 2000;10:319-26.
16. Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, et al. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomarkers Prev. 2007;16:991-7. (Pubitemid 46910102)
17. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41:28-44.
18. Grulich AE, Bataille V, Swerdlow AJ, Newton-Bishop JA, Cuzick J, Hersey P, McCarthy WH. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer. 1996;67:485-91. (Pubitemid 26274103)
19. Garbe C, Büttner P, Weiss J, Soyer HP, Stocker U, Krüger S, et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol. 1994;102:700-5. (Pubitemid 24144246)
20. Hofmann-Wellenhof R, Soyer PH. Atypical (Dysplastic) Nevus. In: Soyer HP, Argenziano G, Hofmann-Wellenhof R, Johr RH, ed. Color Atlas of Melanocytic Lesions of the Skin. v.1. Berlin: Springer-Verlag Berling Heidelberg; 2007. p87-96.
21. Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol. 1987;17:571-83.
22. Soares de Sa BC, Rezze GG. Dermatoscopia dos nevos atípicos. In: Rezze GG, Soares de Sa BC, Neves RI, eds. Atlas de dermatoscopia Aplicada ("Atlas on Dermoscopy"). São Paulo: Lemar; 2004. v. 1. p. 103-7.
23. Rezze GG, Sá BCS, Neves RI. Dermatoscopia: o método de análise de padrões. An Bras Dermatol. 2006;81:261-8.
24. Fikrle T, Pizinger K. Dermatoscopic differences between atypical melanocytic naevi and thin melanomas. Melanoma Res. 2006;16:45-50. (Pubitemid 44133050)
25. Annessi G, Bono R, Sampogna F, Faraggiana T, Abeni D. Sesitivity, specificity and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions. J Am Acad Dermatol. 2007;56:759-67.
26. Elder DE. The dysplastic nevus. Phatology. 1985; 17: 291-7. (Pubitemid 16251032)
27. Clark Jr. WH, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ. Origin of familial malignantmelanomas from heritable melanocytic lesions. The B-K mole syndrome. Arch Dermatol. 1978;114:732-8.
28. Duncan LM, Berwick M, Bruijn JA, Byers HR, Mihm MC, Barnhill RL. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol. 1993;100:S318-321.
29. Brochez L, Verhaeghe E, Grosshans E, Haneke E, Piérard G, Ruiter D, Naeyaert JM. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol. 2002;196:459-66. (Pubitemid 34262859)
30. Piepkorn M, Meyer LJ, Goldgar D, Seuchter SA, Cannon-Albright LA, Skolnick MH, Zone JJ. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol. 1989;20:407-15. (Pubitemid 19086775)
31. Annessi G, Cattaruzza MS, Abeni D, Baliva G, Laurenza M, Macchini V, et al. Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. J Am Acad Dermatol. 2001;45:77-85.
32. Bertram CG, Gaut RM, Barrett JH, Pinney E, Whitaker L, Turner F, et al. An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. J Invest Dermatol. 2002;119:961-5.
33. Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, Cuzick J. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer. 1996;73:1605-11. (Pubitemid 26235392)
34. Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res. 2006;66:9818-28. (Pubitemid 44672032)
35. Pho L, Grossman D, Leachman SA. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma. Curr Opin Oncol. 2006;18:173-9. (Pubitemid 43740438)
36. Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet. 2007;44:99-106.
37. Goldstein AM, Chidambaram A, Halpern A, Holly EA, Guerry IV D, Sagebiel R, et al. Rarity of CDK4 germline mutations in familial melanoma. Melanoma Res. 2002;12:51-5. (Pubitemid 34183689)
38. Majore S, De Simone P, Crisi A, Eibenschutz L, Binni F, Antigoni I, et al. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma. Pigment Cell Res. 2008;21:209-11. (Pubitemid 351551225)
39. Rezze GG, Leon A. Nevo Displasico. In: Belfort FA, Wainstain AJA, eds. Melanoma diagnostico e tratamento. São Paulo: Lemar; 2009. v. 1. p. 99-110.